World-Class Cancer Care, Now Within Reach

The sixth-generation CyberKnife M6 is a fully digital whole-body stereotactic X-ray radiosurgery system with a multi-leaf collimator. It tracks the patient's position, tumor location and respiratory motion in real time, correcting the beam during treatment.

• Short course — only 1–5 sessions to treat the tumor, completed in the outpatient department.
• Sub-millimeter precision (system error < 0.95 mm) with minimal damage to normal tissue.
• Non-invasive, painless, no anesthesia, short recovery and few side effects.

Indications: Primary head and neck tumors, early and advanced lung cancer, lung metastases, spinal metastases, pancreas, prostate — benign and malignant tumors across the body.

★ Installed 2019; radiotherapy license July 7, 2020; our first CyberKnife case July 10, 2020.

Our TomoTherapy system integrates IMRT, IGRT and DGRT, seamlessly combining a linear accelerator with helical CT to deliver 360° focal layer irradiation under CT guidance.

• Imaging accuracy up to ±0.1 mm, with dual high precision in both position and dose.
• Irradiates multiple tumor lesions in one session, protecting vital organs.
• Extremely wide clinical application — covers almost all cases suitable for radiotherapy.

Indications: Complex head and neck tumors, intracranial tumors, whole bone marrow irradiation, pelvic tumors, liver, lung and pancreatic cancer.

★ Clinical evidence confirms helical Tomotherapy significantly increases survival while reducing radiation reactions and complications.

One of the world's most advanced new-generation linear accelerators, equipped with the latest HyperArc technology for image-guided radiotherapy and radiosurgery.

• HyperArc "super-arc knife" treats several to dozens of brain metastases within 10 minutes.
• Greatly improves the speed and accuracy of tumor treatment.
• Enables stereotactic body radiotherapy (SBRT) with an intelligent quality-control system.

Indications: Image-guided radiotherapy and radiosurgery for tumors across the body; HyperArc for multiple brain metastases.

★ Our first HyperArc case October 28, 2020; first respiratory gating case May 11, 2020.

The world's first 100% image-guided, fully digital and AI-driven radiotherapy linear accelerator.

• High speed — the whole treatment takes only 6–8 minutes.
• Unique dual-layer high-speed multi-leaf collimator for precise dose delivery.
• 100 cm open bore, quiet and comfortable environment that reduces patient anxiety.

Indications: Head and neck, intracranial, lung, breast, nasopharyngeal, prostate, rectal, esophageal and bone tumors.

★ Upgraded to v4.0 on September 15, 2025 — China's first device with HyperSight image guidance; first HyperSight case September 16, 2025.

Varian's fifth-generation brachytherapy afterloader, designed for 3D conformal high-dose-rate internal irradiation through natural cavities or interstitial implantation.

• High-activity source delivers high-dose-rate irradiation to local tumors.
• Short treatment time — can be performed on an outpatient basis.
• High safety, effectively reducing side effects, complications and local recurrence.

Indications: Cervical, endometrial, breast, esophageal, rectal, skin and tongue cancers.

★ Definitive radiotherapy (external beam + brachytherapy) led to complete disappearance of large cervical tumors.

The world's first AI-based online adaptive radiotherapy platform — before every session it re-images the patient and adjusts the target volume and plan in real time.

• AI-guided workflow with effortless, efficient quality control.
• Every treatment is precisely projected onto the tumor — individualized radiotherapy each time.
• Clear advantage for tumors affected by bowel and bladder filling (prostate, bladder, cervix, rectum).

Indications: Head and neck, lung, esophageal, breast, prostate, bladder, cervical and rectal cancers.

★ Installed September 2022; license April 7, 2023; first adaptive case April 16, 2023.

Dual-energy, four-dimensional large-aperture spiral CT — the industry's highest multi-layer large-bore CT with the fastest rotation and largest HD field of view.

• Unique dual-energy scanning platform effectively reduces metal artifacts.
• The industry's first "full-aperture" positioning CT — especially effective for larger patients.
• Self-breath-hold gated scanning solves the challenge of moving organs.

Indications: Rapid, accurate simulation positioning and image acquisition for all body regions and positions.

The MR-only solution generates "synthetic CT" directly from high-resolution MRI with zero radiation — one scan for both precise target delineation and dose calculation.

• Zero radiation — ideal for children, pregnant patients and repeat treatments.
• 4D MRI self-gating captures organ motion during free breathing — no breath-holds needed.
• Superior soft-tissue contrast for more accurate target delineation.

Indications: Precision radiotherapy simulation for head and pelvic tumors.

★ First MRI-based synthetic CT May 28, 2025; first 4D MRI gating July 4, 2025; distributed MRI adaptive therapy September 22, 2025.